ANTICARDIOLIPIN ANTIBODIES AND ANTIPHOSPHOLIPID SYNDROME IN CHRONIC DISCOID LUPUS-ERYTHEMATOSUS

被引：10

作者：

RUFFATTI, A

VELLERFORNASA, C

PATRASSI, GM

SARTORI, E

TONELLO, M

TONETTO, S

PESERICO, A

TODESCO, S

机构：

[1] Division of Rheumatology, University of Padova, Padova, 35128, Via Giustiniani

[2] Department of Dermatology, University of Padova, Padova, 35128, Via Giustiniani

[3] IVth Chair of Internal Medicine, University of Padova, Padova, 35128, Via Giustiniani

来源：

CLINICAL RHEUMATOLOGY | 1995年 / 14卷 / 04期

关键词：

CHRONIC DISCOID LUPUS ERYTHEMATOSUS; ANTICARDIOLIPIN ANTIBODIES; ANTIPHOSPHOLIPID SYNDROME;

D O I：

10.1007/BF02207672

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Anticardiolipin antibodies (aCL) of immunoglobulin (Ig) G and M classes were determined in 28 patients affected with chronic discoid lupus erythematosus (CDLE), comparing their prevalence and levels to those in 60 healthy subjects matched for age and sex. A high and significant frequency of IgG (67.8%) and IgM (50.0%) aCL together with prevalence of high antibody levels was found in CDLE patients, while healthy controls had IgG and IgM aCL in 1.6% and 3.3% of cases respectively. Clinical features in keeping with the diagnosis of antiphospholipid syndrome were found in one patient (3.5%), which, as the first manifestation of the syndrome, showed a pulmonary thromboembolism which appeared some days after prolonged exposure to the sun. These results provide additional data on autoimmune phenomena in CDLE and suggest that aCL test should be considered as useful aids in immunological diagnosis of CDLE.

引用

页码：402 / 404

页数：3

共 11 条

[1]

Harris E.N., Khamashta M.A., Hughes G.R.V., Antiphospholipid antibody syndrome, Arthritis and Allied Conditions, pp. 1201-1212, (1993)

[2]

Love P.E., Santoro S.A., Antiphospholipid antibodies: Anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders, Ann Intern Med, 112, pp. 682-698, (1990)

[3]

Kind P., Schuppe H.C., Jung K.P., Degitz K., Lakomek H.J., Goerz G., Kutaner Lupus erythematodes und KardiolipinAntikorper. Vorkommen und klinische bedeutung, Hautarzt, 43, pp. 126-129, (1992)

[4]

Tebbe B., Orfanos C.E., Anticardiolipin-antikorper beim Kutanen Lupus erythematodes. Vorkommen und bedeutung als marker vaskularer symptomatik, Hautartz, 43, pp. 130-133, (1992)

[5]

Tan E., Cohen A.S., Fries J.F., Et al., The 1982 revised criteria for the classification of systemic lupus erythematosus, Arthritis Rheum, 25, pp. 1271-1277, (1982)

[6]

Ackerman A.B., Superficial and deep perivascular dermatitis, Histologic Diagnosis of Inflammatory Skin Diseases, pp. 306-315, (1978)

[7]

Gharavi A.E., Harris E.N., Asherson R.A., Huges G.R.V., Anticardiolipin antibodies: isotype distribution and phospholipid specificity, Ann Rheum Dis, 46, pp. 1-6, (1987)

[8]

Weinstein M.C., Fineberg H.V., Clinical decision analysis, pp. 114-127, (1980)

[9]

Ruffatti A., De Silvestro G., Ghirardello A., Et al., A catastrophic antiphospholipid syndrome: the importance of high levels of warfarin anticoagulation, J Intern Med, 235, pp. 81-83, (1994)

[10]

Lehmann P., Holze E., Kind P., Goerz G., Plewig G., Experimental reproduction of skin lesions in lupus erythematosus by UVA and UVB radiation, J Am Acad Dermatol, 22, pp. 181-187, (1990)

← 1 2 →